Avexa Reports Positive Phase IIb Result
...)--Mar 20, 2007 - Australian
biotechnology company avexa
(ASX:AVX) today announced highly
successful result...esenting greater than 50% of the overall market.
Limited is a Melbourne-based biotechnology company...eases which have a
significant unmet medical need. avexa
has dedicated resources and
funding for key projec...
Avexa's Apricitabine Clinical Trial Update
...E)--Jul 5, 2007 - Australian
biotechnology company avexa
(ASX:AVX) announced today the
completion of aprici...rom the 24 week blinded
phase later this quarter.
also reported that apricitabine continues to maint...for
HIV," stated Dr. Julian Chick, CEO of Avexa.
Limited is a Melbourne-based biotechnology company...
Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts
Monogram Assays to be used by Avexa
to select patients and optimize background therapy in phase III program
SOUTH SAN FRANCISCO, Calif., March 10 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc., (Nasdaq: MGRM ) announced today that the Company
has signed an agreement wit...
Cytopia Letter to Progen Shareholders
...y Phase III program, this time in HIV;
HIV drug development costs are estimated at $155 m...commendation: Shareholders should vote against the avexa
merger by voting "NO" for ALL resolutions and, if ...ard is not supporting a share buy-back without the avexa
merger, we recommend you vote against all of the r...
Progen Concedes Shareholder Requisitioned Meeting
- persists with high risk, high funding, avexa
-- Shareholders denied sing...bination of the two.
The merger proposal with avexa
Limited (ASX:AVX) only allows for up to a $20 mill...resented at each meeting.
Proposed Progen and avexa
The material submitted by the Progen b...
Cytopia and Other Progen Shareholders Maintain Call for Meeting
...oard appears committed to its merger proposal with avexa
Limited (ASX: AVX) and a limited share buyback, to...is should be held at the same time any merger with avexa
is considered to allow the Progen shareholders to ... Accordingly, the general meeting to consider the avexa
merger should be delayed to enable all of the prop...
Progen Shareholders Call Meeting to Spill Progen Board and Offer Merger or Full Cash Back to Shareholders
... general meeting is held to consider the proposed merger between Progen and avexa
Ltd (ASX: AVX). This will give shareholders much greater flexibility of cho...eserves. This is currently denied to Progen shareholders under the proposed avexa
merger terms where only $20 million is available for the share buyback.
Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
...dual rights (for
the US and Canada) for the investigational HIV compound to avexa
("Avexa") on January 23, 2007. In return Shire received an upfront cash
payment of $10 million and avexa
shares valued at approximately $3 million.
- In April 2007 Shire complete...